Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. padicare

PaDiCare

Patient empowered Diabetes care in ambulatory settings

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 PaDiCare project word cloud

Explore the words cloud of the PaDiCare project. It provides you a very rough idea of what is the project "PaDiCare" about.

labs    diseases    lipid    time    efficient    itc4u    staff    transmits    proper    atonomics    perform    finger    share    introduction    patient    assays    doctor    accessibility    saving    daily    bottleneck    rooms    pricking    opentele    chronic    waiting    min    point    infrastructure    biomarker    sync    grade    combines    sustainability    accurate    hours    faster    diabetes    vision    involvement    expand    turnover    app    pc    benefit    diabetic    syncs    automatically    runs    appointments    platform    efficiency    patients    mellitus    biomarkers    glucose    helps    source    procedure    collected    dm    hospitals    electronic    epr    hba1c    drop    record    care    analysing    panel    resource    draw    lab    nurses    blood    services    trace    precise    hospital    tablet    doctors    assay    ambulatory    collects    monitoring    device    option    guided    simplified    market    secure    performing    joint    data    clinicians    intelecare4u    poc    regular    synced    trips    run   

Project "PaDiCare" data sheet

The following table provides information about the project.

Coordinator		 ATONOMICS AS 

Organization address
address: VESTRE TEGLGADE 10
city: KOBENHAVN
postcode: 2750
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Denmark [DK]
 Project website http://www.padicare.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ATONOMICS AS DK (KOBENHAVN) coordinator 50˙000.00
2    INTELECARE4U APS DK (AARHUS C) participant 0.00

Map

 Project objective

Atonomics and InTeleCare4U’s joint vision is to bring Trace to market, a Point-of-Care (POC) blood biomarker monitoring system for Diabetes Mellitus (DM) that syncs highly accurate and precise lab results to hospital’s electronic patient record (EPR). Trace has such a simplified user experience that patients can perform their own blood analysis without nurses performing the blood draw or lab staff analysing the sample. Trace analysis require just a drop of blood obtained through finger-pricking, the same procedure that diabetic patients use for daily glucose monitoring. Analysis runs automatically in a very short time (5-7 min per biomarker) and the results are then synced to doctors’ PC / tablet through ITC4U’s data sync services – based on the open source OpenTele platform. Trace system combines the following three key elements for effective and resource-efficient monitoring: - Trace device, an easy to use, lab-grade device to measure HbA1c and lipid panel biomarkers for DM monitoring; - Trace tablet app, a step-guided application that helps patients use the Trace device, and collects the results from Trace; - ITC4U’s secure sync infrastructure that transmits patient data collected in app directly to the doctor’s tablet or PC.

With the growing share of DM patients, the availability of clinicians will become a bottleneck for proper care. Patient involvement in these analyses is the best option for sustainability of care. Trace addresses this market. The short assay run time means that patients can perform blood analysis just before their regular appointments, already at the ambulatory unit, saving hours in waiting rooms and trips to labs. Hospitals benefit from faster patient turnover, providing care to more patients with the same resources (i.e. higher efficiency and higher care accessibility). Over time, Trace will be able to expand biomarker monitoring to other chronic diseases, through the development and market introduction of further assays for Trace.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PADICARE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PADICARE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

JUMPAIR (2018)

Decubitus Ulcers Diseases Diagnoses by means of Smart ICT Anti-Decubitus System based on known Ulcers Activity Biomarkers

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More